AKT Inhibition in Prostate Cancer — Proceedings from a Session Held Adjunct to the 2026 ASCO Genitourinary Cancers Symposium
Oncology Today with Dr Neil Love
00:00
Lutetium-177 Considerations in mHSPC
Karim Fizazi shares skepticism about magnitude of benefit seen with early lutetium in hormone-sensitive trials.
Play episode from 01:26:46
Transcript
